Montreal researchers have developed a new tool to fight glioblastoma, a brain cancer so ruthless that some call it the ‘Terminator’.

Modern medicine is essentially powerless against glioblastoma, and patients’ life expectancy is only a year or two after diagnosis.

The goal of the new tool, called Sentry, is to improve this statistic by helping surgeons remove as many cancer cells as possible before they can regenerate.

“Glioblastoma is a very aggressive cancer. The prognosis for patients depends largely on the amount of tumor that remains after surgery,” explained Dr. Kevin Petrecca, head of neurology at the McGill University Health Centre (MUHC).

“Radiation and chemotherapy are not curative. But if we can reduce the number of cancer cells to a very small number, it is possible to achi

See Full Page